✨ Health and Tax Notices
NEW ZEALAND GAZETTE
9 FEBRUARY
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Naproxen 250 mg, 500 mg | |||
| Piretamide 6 mg | Tablet | Apotex Inc., Canada | |
| Hoechst AG, Federal Republic of Germany | Arelix | ||
| Lorazepam 1 mg, 2.5 mg | Tablet | Glaxo NZ Ltd., Palmerston North | |
| Atenolol 50 mg, 100 mg | Tablet | Apotex Inc., Canada | |
| Naproxen 250 mg, 500 mg | Tablet | Clonmel Chemicals Co. Ltd., Ireland | |
| Terazosin hydrochloride 1 mg, | |||
| 2 mg, 5 mg, 10 mg | Tablet | Abbott Laboratories Aust Pty Ltd., Australia, Abbott Laboratories Ltd., USA and United Kingdom | Hytrin |
| Sulindac 100 mg, 150 mg, | |||
| 200 mg | Tablet | Novopharm Ltd., Canada | Saldac |
| Calcium carbonate 500 mg | Tablet | Norcliff Thayer Inc., USA | Tums |
| Fluoxetine hydrochloride 60 mg | Capsule | Eli Lilly International Corporation USA or Elanco S.A. Republic of Ireland | Prozac 60 |
| Idoxuridine 0.5% | Cream | Milpharma Pty Ltd., Australia | Virasolve |
| Lignocaine hydrochloride 2% | |||
| Benzalkonium chloride 0.5% | Impregnated gauze | Aco Lakemedel, Sweden | Acoband |
| Zinc oxide 200 mg/1 g | |||
| Water for injection 2 ml, 5 ml, | |||
| 10 ml, 20 ml | Ampoule | The Boots Company (Australia) Pty Ltd., Australia | |
| Sodium bicarbonate 8.4% w/v 10 ml | Ampoule | The Boots Company (Australia) Pty Ltd., Australia | |
| Adrenaline acid tartrate 1 mg/ml | Ampoule | The Boots Company (Australia) Pty Ltd., Australia | |
| Potassium dihydrogen phosphate 0.54 g in 10 ml | Ampoule | David Bull Laboratories Pty Ltd., Australia | |
| Dipotassium hydrogen phosphate 1.83 g in 10 ml | Ampoule | ||
| Potassium dihydrogen phosphate 1.35 g in 10 ml | |||
| Triamcinolone acetonide 40 mg/ml | Suspension for injection | Steris Laboratories Inc., USA | |
| Vancomycin hydrochloride 500 mg | Powder in vial | Lederle Parentals Inc., USA | Vancoled |
| Dextrose hydrous 1.5%, 2.5%, | |||
| 4.25% w/v with sodium chloride 0.538% w/v, sodium lactate 0.448% w/v, calcium chloride 0.257% w/v, magnesium chloride 0.00508% w/v | Solution | Delmed Inc., USA | Peritosteril |
Dated this 25th day of January 1989.
DAVID CAYGILL, Minister of Health.
go1831
Inland Revenue
Income Tax Act 1976
Determination E4: Persons Not Required to Comply with Section 104A of the Income Tax Act 1976
-
Reference—This determination is made pursuant to section 104A (5) of the Income Tax Act 1976. It determines the extent to which persons are not required to comply with section 104A of the Income Tax Act 1976, in respect of the income year commencing on the 1st day of April 1988.
-
Interpretation—In this determination, unless the context otherwise requires—
Expressions used have the same meanings as in section 2 and section 104A of the Income Tax Act 1976:
Every reference to an income year shall, where a person furnishes a return of income under section 15 of the Income Tax Act 1976, for an accounting year ending with a day other than the 31st day of March, be deemed to be a reference to the accounting year corresponding with that income year and, in every such case, this determination shall, with necessary modifications, apply accordingly.
-
Audit fees in relation to a person and an income year means fees payable by the person to a qualified person in relation to the preparation of a report relating to any financial statement relating to the person and the income year for financial reporting purposes.
-
Balance date, in relation to a person and an income year, means the last day of the person’s income year.
-
Expenditure means accrual expenditure.
-
Expiry date, in relation to any expenditure incurred in an income year, means—
(a) Where the expenditure relates to payment for services, the date by which it is reasonably expected that performance of the service will be completed;
(b) Where the expenditure relates to payment for, or in relation to, a chose in action—
(i) For a definite period, the last day of that period;
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1989, No 22
NZLII —
NZ Gazette 1989, No 22
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines under the Medicines Act 1981
(continued from previous page)
🏥 Health & Social Welfare25 January 1989
Health, Medicines, Distribution, Act 1981
- DAVID CAYGILL, Minister of Health
💰 Income Tax Act 1976 Determination E4
💰 Finance & RevenueIncome Tax, Determination, Audit fees, Expenditure